Virtual weight control program aimed at diabetes management pulled before start

NCT ID NCT05663554

Terminated Disease control Sponsor: Pennington Biomedical Research Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study planned to test whether a virtual weight control program (WW, formerly Weight Watchers) could help adults with type 2 diabetes and obesity lower their blood sugar levels. Participants would have used the WW SmartPoints system and attended weekly online workshops. However, the study was withdrawn before enrolling anyone, so no data were collected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WW virtual weight control program (behavioral intervention using SmartPoints system)
What this could lead to: If it had succeeded, this could have pointed toward a practical, scalable way to help people with type 2 diabetes improve blood sugar control through weight management.
What could go wrong: The study was withdrawn before enrolling any participants, so no results are available. Even if conducted, behavioral programs can have variable adherence and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2 OBESITY

Contacts and locations

Locations

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States
University of Pittsburgh Health Sciences

Pittsburgh, Pennsylvania, 15261, United States
Wake Forest University Health Sciences

Greensboro, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.